ES2103121T3 - Complejos derivatizados de dtpa, agentes farmaceuticos que contienen estos compuestos, su utilizacion como agentes de contraste de rmn y de rayos x, y procedimiento para su preparacion. - Google Patents

Complejos derivatizados de dtpa, agentes farmaceuticos que contienen estos compuestos, su utilizacion como agentes de contraste de rmn y de rayos x, y procedimiento para su preparacion.

Info

Publication number
ES2103121T3
ES2103121T3 ES94904643T ES94904643T ES2103121T3 ES 2103121 T3 ES2103121 T3 ES 2103121T3 ES 94904643 T ES94904643 T ES 94904643T ES 94904643 T ES94904643 T ES 94904643T ES 2103121 T3 ES2103121 T3 ES 2103121T3
Authority
ES
Spain
Prior art keywords
compounds
pct
nmr
dtpa
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94904643T
Other languages
English (en)
Inventor
Heribert Schmitt-Willich
Johannes Platzek
Heinz Gries
Bernd Raduchel
Orlin Petrov
Andreas Muhler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2103121T3 publication Critical patent/ES2103121T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/76—Metal complexes of amino carboxylic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS COMPLEJOS Y SUS SALES CONSISTIENDO EN AL MENOS UN ION METALICO Y UN AGENTE DISPONIENDO DE FORMULA GENERAL (I), EN DONDE Z{SUP.1} Y Z{SUP.2} REPRESENTAN DE FORMA INDEPENDIENTE UNO DE OTRO UN ATOMO DE HIDROGENO, EL RESTO - (CH{SUB.2}){SUB.M} - C{SUB.6}H{SUB.4}){SUB.Q} (O){SUB.K} - (CH{SUB.2}){SUB.N} - (C{SUB.6}H{SUB.4}){SUB.1} (O){SUB.R} - R O EL RESTO - (CH{SUB.2}){SUB.M} (C{SUB.6}H{SUB.10}){SUB.Q} - (O){SUB.K} - (CH{SUB.2}){SUB.N} (C{SUB.6}H{SUB.10}{SUB.1} - (O){SUB.R} - R, DONDE M Y N SON LOS NUMEROS 0-5, Q, K, L Y R CON LOS NUMEROS 0 O 1 Y S SON LOS NUMEROS 1 O 2; R ES UN ATOMOS DE HIDROGENO, SUSTITUIDO SI SE REQUIERE POR OR{SUP.1} -, RESTO C{SUB.1} - C{SUB.6} - ALQUIL DE CADENA RECTA O DE CADENA RAMIFICADA O UN GRUPO CH{SUB.2} COOR{SUP.1}, DONDE R{SUP.1} ES UN ATOMO DE HIDROGENO, UN RESTO DE C{SUB.1} - C{SUB.6} - ALQUIL O UN GRUPO BENCIL, CON LA PREVISION DE QUE UNO DE LOS SUSTITUYENTES Z{SUP.1} O Z{SUP.2} ES UN ATOMO DE HIDROGENO Y EL OTRO NO LO ES,Y QUE NO PERMITA UN ENLACE DIRECTO OXIGENO-OXIGENO. SE DESCRIBE TAMBIEN SU UTILIZACION PARA AGENTES DE RADIOTERAPIA Y NMR Y AGENTES DE DIAGNOSTICO RADIOGRAFICO, EN PARTICULAR PARA CONTRASTADO DE SISTEMA HEPATOBILIAR. SE DESCRIBE TAMBIEN UN PROCESO PARA LA ELABORACION DE ESTOS COMPUESTOS Y AGENTES.
ES94904643T 1993-01-25 1994-01-08 Complejos derivatizados de dtpa, agentes farmaceuticos que contienen estos compuestos, su utilizacion como agentes de contraste de rmn y de rayos x, y procedimiento para su preparacion. Expired - Lifetime ES2103121T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4302287A DE4302287A1 (de) 1993-01-25 1993-01-25 Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltende pharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
ES2103121T3 true ES2103121T3 (es) 1997-08-16

Family

ID=6479074

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94904643T Expired - Lifetime ES2103121T3 (es) 1993-01-25 1994-01-08 Complejos derivatizados de dtpa, agentes farmaceuticos que contienen estos compuestos, su utilizacion como agentes de contraste de rmn y de rayos x, y procedimiento para su preparacion.

Country Status (18)

Country Link
US (1) US5733522A (es)
EP (1) EP0680464B1 (es)
JP (1) JPH08506102A (es)
KR (1) KR960700219A (es)
AT (1) ATE151406T1 (es)
AU (1) AU681620B2 (es)
CA (1) CA2154559A1 (es)
DE (2) DE4302287A1 (es)
DK (1) DK0680464T3 (es)
ES (1) ES2103121T3 (es)
GR (1) GR3023954T3 (es)
HU (1) HUT72628A (es)
IL (1) IL108433A (es)
NO (1) NO302575B1 (es)
NZ (1) NZ259708A (es)
TW (1) TW314520B (es)
WO (1) WO1994017029A1 (es)
ZA (1) ZA94512B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19507820A1 (de) * 1995-02-21 1996-08-22 Schering Ag Neuartig substituierte DTPA-Derivate, deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik, sowie Verfahren zur Herstellung der Komplexe und Mittel
IT1290417B1 (it) * 1996-08-02 1998-12-03 Bracco Spa Composti chelanti derivati di acidi poliamminopolicarbossilici, loro chelati con ioni metallici paramagnetici, loro preparazione ed
US6458337B1 (en) 1996-08-02 2002-10-01 Dibra S.P.A Diagnostic imaging contrast agent with improved in serum relaxivity
US6403055B1 (en) 1996-08-02 2002-06-11 Dibra S.P.A. Diagnostic imaging contrast agent with improved in serum relaxivity
DE19641197C2 (de) * 1996-09-24 1999-02-18 Schering Ag Ionenpaare und ihre Verwendung als Kontrastmittel
DE19646762B4 (de) * 1996-11-04 2004-05-13 Schering Ag Verwendung von Metallverbindungen zur Herstellung von Mitteln zur Strahlentherapie von Tumoren
US20060099142A1 (en) * 2002-03-14 2006-05-11 Delaney Allen D Cancer associated araf1 protein kinase and its uses
US20070048803A1 (en) * 2005-08-25 2007-03-01 Lee Peter P Immune profiling of lymph nodes associated with cancer
EP3212610B1 (en) 2014-10-30 2020-10-28 Katholieke Universiteit Leuven Methods for low temperature fluorine-18 radiolabeling of biomolecules

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA713093A (en) * 1965-07-06 Dexter Martin Complex forming polyaminopoly-carboxylic acids
DE1155122B (de) * 1960-10-17 1963-10-03 Geigy Ag J R Verfahren zur Herstellung von neuen alicyclischen Polyaminopolyessigsaeuren bzw. deren komplexen Metallverbindungen
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3324235A1 (de) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen Neue komplexbildner, komplexe und komplexsalze
US4880008A (en) * 1985-05-08 1989-11-14 The General Hospital Corporation Vivo enhancement of NMR relaxivity
IT1213029B (it) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
US5039512A (en) * 1986-08-04 1991-08-13 Salutar, Inc. NMR imaging with paramagnetic polyvalent metal salts of poly-(acid-alkylene-amino)-alkanes
AU608759B2 (en) * 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
US5482700A (en) * 1987-03-31 1996-01-09 Schering Aktiengesellschaft Substituted polyamino, polycarboxy complexing agent dimers for MRI and X-ray contrast
US5198208A (en) * 1987-07-16 1993-03-30 Nycomed Imaging As Aminopolycarboxylic acids and derivatives thereof
US5399340A (en) * 1987-09-24 1995-03-21 Schering Aktiengesellschaft Use of amide complex compounds
US5021571A (en) * 1989-06-29 1991-06-04 Associated Universities, Inc. Cyclohexyl EDTA monoanhydride
US5089663A (en) * 1989-06-29 1992-02-18 Associated Universities, Inc. Cyclohexyl-triethylenetetraamine hexacetic acid
DE3922005A1 (de) * 1989-06-30 1991-01-10 Schering Ag Derivatisierte dtpa-komplexe, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
US5124471A (en) * 1990-03-26 1992-06-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Bifunctional dtpa-type ligand
AU6996594A (en) * 1993-06-02 1994-12-20 Bracco S.P.A. Iodinated paramagnetic chelates, and their use as contrast agents
JPH09505819A (ja) * 1993-12-03 1997-06-10 ブラッコ エッセ．ピ．ア． 核磁気共鳴診断用常磁性キレート

Also Published As

Publication number Publication date
HUT72628A (en) 1996-05-28
DK0680464T3 (da) 1997-10-20
NO952925L (no) 1995-07-24
NO302575B1 (no) 1998-03-23
DE59402379D1 (de) 1997-05-15
IL108433A0 (en) 1994-04-12
WO1994017029A1 (de) 1994-08-04
ATE151406T1 (de) 1997-04-15
GR3023954T3 (en) 1997-09-30
EP0680464A1 (de) 1995-11-08
IL108433A (en) 1999-03-12
AU681620B2 (en) 1997-09-04
TW314520B (es) 1997-09-01
EP0680464B1 (de) 1997-04-09
US5733522A (en) 1998-03-31
DE4302287A1 (de) 1994-07-28
ZA94512B (en) 1994-09-05
KR960700219A (ko) 1996-01-19
NO952925D0 (no) 1995-07-24
HU9501878D0 (en) 1995-08-28
JPH08506102A (ja) 1996-07-02
NZ259708A (en) 1997-01-29
AU5860494A (en) 1994-08-15
CA2154559A1 (en) 1994-07-26

Similar Documents

Publication Publication Date Title
Shibamoto et al. Supratentorial low‐grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variables
ATE195432T1 (de) Iodierte paramagnetische chelaten, und deren verwendung als kontrastmittel
Heverhagen et al. Application of extracellular gadolinium-based MRI contrast agents and the risk of nephrogenic systemic fibrosis
PL324342A1 (en) Complex compounds of a cascade polymer, method of obtaining them and pharmaceutic agents containing such compounds
ES2140409T3 (es) Agente de contraste para rayos x.
ATE159522T1 (de) Fluorhaltige makrocyclische metallkomplexe
PL309395A1 (en) Injectable aqueous preparations useful in x-ray diagnostics, containing iodised aromatic compounds used as x-raying contrast media
WO1996016929A1 (de) Neuartige, mehrfach substituierte dtpa-derivate und deren metallkomplexe, diese komplexe enthaltende pharmazeutische mittel, deren verwendung in der diagnostik und therapie, sowie verfahren zur herstellung der komplexbildner und komplexe und verfahren zur herstellung pharmazeutischer mittel
ES2103121T3 (es) Complejos derivatizados de dtpa, agentes farmaceuticos que contienen estos compuestos, su utilizacion como agentes de contraste de rmn y de rayos x, y procedimiento para su preparacion.
DE69019584D1 (de) Makrocyclische Stickstoffliganden Verfahren zu ihrer Herstellung, ihre Metallkomplexe, sie enthaltende Diagnostische und therapeutische Mittel.
HU9601742D0 (en) Metalcomplexes of dendrimeric molecules, diagnostic agents containing them and process for producing the complexes and agents
KR930019648A (ko) 테트라아자시클로도덴칸 유도체 및 그의 용도
ES2134487T3 (es) Derivados dimeros de dtpa y sus complejos con metales, agentes farmaceuticos que contienen estos complejos, su utilizacion en el diagnostico y la terapia, asi como procedimientos para la preparacion de los complejos y agentes.
Ham et al. Dialysis osteomalacia: a possible role for zirconium as well as aluminium
Mulvaney et al. Deposition of tetracyclines in urinary calculi
DIETRICH et al. E. WERNER, P. ROTH, U. BÖHNERT, U. ELSASSER, K. HENRICHS
Celić et al. The possible role of radiation in the etiopathogenesis of lymphomatoid papulosis
Hardy et al. The detection of bone lesions using 99Tcm labelled polyphosphate
Hall et al. Gold nephropathy
Miller et al. Abstracts of Current Literature

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 680464

Country of ref document: ES